Page last updated: 2024-10-26

valproic acid and Anemia, Hemolytic, Autoimmune

valproic acid has been researched along with Anemia, Hemolytic, Autoimmune in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Anemia, Hemolytic, Autoimmune: Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Watanabe, T1
Nakayasu, K1
Nagayama, Y1

Other Studies

1 other study available for valproic acid and Anemia, Hemolytic, Autoimmune

ArticleYear
Autoimmune haemolytic anaemia and renal Fanconi syndrome caused by valproate therapy.
    European journal of pediatrics, 2005, Volume: 164, Issue:3

    Topics: Anemia, Hemolytic, Autoimmune; Anticonvulsants; Child, Preschool; Epilepsy; Fanconi Syndrome; Female

2005